Literature DB >> 7940182

Analysis of clinicopathologic prognostic features in patients with gastric adenocarcinoma.

F Michelassi1, D M Takanishi, D Pantalone, J Hart, R Chappell, G E Block.   

Abstract

BACKGROUND: We evaluated the influence of several clinicopathologic variables on 5-year actuarial survival rate after curative resection of gastric adenocarcinoma.
METHODS: Clinical characteristics were retrieved from the records of all patients who underwent gastric resection for curative intent between 1965 and 1986 at The University of Chicago Medical Center, and follow-up was obtained from our tumor registry. Pathologic characteristics were determined from a detailed review of all available histopathologic slides.
RESULTS: One hundred seventy-eight patients underwent a curative resection during the study period at our institution. Overall 5-year actuarial survival rate was 29%. The relationship between clinicopathologic variables and 5-year survival rate was evaluated by Kaplan-Meier survival curve construction and chi-squared analysis. Lymphatic and/or capillary microinvasion (absent vs present, p < 0.001), tumor location (antrum and body vs gastroesophageal junction, p = 0.05), local extent of disease (limited to the gastric wall versus involving adjacent organs, p = 0.003), stage (absence versus presence of lymph node metastases, p < 0.001), Lauren type (intestinal versus diffuse, p < 0.01), and Ming type (expanding versus infiltrative, p < 0.02) significantly influenced survival. When a multivariate analysis with logistic regression of 5-year survival was performed, lymphatic and/or capillary microinvasion emerged as the only statistically significant, independent prognostic factor associated with long-term survival (p = 0.039). If microinvasion was omitted from the analysis, lymph node metastases (p < 0.05) and the extension to adjacent organs (p < 0.04) became the only statistically significant variables. Multiple correlation analyses suggested that microinvasion is an early histopathologic finding that correlates with a more aggressive natural history.
CONCLUSIONS: Lymphatic and/or capillary microinvasion is a more powerful predictor of 5-year survival than lymph node metastases or tumor extension to adjacent organs. Correlation among clinicopathologic variables suggests that microinvasion may represent an early finding, serving as a potential marker for a biologically more aggressive tumor.

Entities:  

Mesh:

Year:  1994        PMID: 7940182

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  10 in total

1.  Prognostic significance of host- and tumor-related factors in patients with gastric cancer.

Authors:  Yasuhiko Mohri; Kouji Tanaka; Masaki Ohi; Takeshi Yokoe; Chikao Miki; Masato Kusunoki
Journal:  World J Surg       Date:  2010-02       Impact factor: 3.352

2.  Survival after gastric adenocarcinoma resection: eighteen-year experience at a single institution.

Authors:  Steven C Cunningham; Farin Kamangar; Min P Kim; Sommer Hammoud; Raqeeb Haque; Anirban Maitra; Elizabeth Montgomery; Richard E Heitmiller; Michael A Choti; Keith D Lillemoe; John L Cameron; Charles J Yeo; Richard D Schulick
Journal:  J Gastrointest Surg       Date:  2005 May-Jun       Impact factor: 3.452

3.  Expression profile as predictor of relapse after adjuvant treatment in gastric cancer.

Authors:  María Sereno; Javier De Castro; Paloma Cejas; Miguel Angel García-Cabezas; Cristóbal Belda; Enrique Casado; Jaime Feliu; César Gómez; Miriam López; Manuel González Barón
Journal:  J Gastrointest Cancer       Date:  2012-06

4.  Alpha-fetoprotein-producing adenocarcinoma in which the metastatic route was determined from calcified lesions.

Authors:  Atsunori Tsuchiya; Tsutomu Kanefuji; Takeshi Suda; Tomoya Aoyagi; Akihiko Osaki; Tadayuki Togashi; Yusuke Kawauchi; Mae Fushiki; Gen Watanabe; Masaki Hirota; Minoru Nomoto; Yoichi Ajioka; Yutaka Aoyagi
Journal:  Clin J Gastroenterol       Date:  2011-02-25

5.  Risk factors of survival and surgical treatment for advanced gastric cancer with large tumor size.

Authors:  Chen Li; Sung Jin Oh; Sungsoo Kim; Woo Jin Hyung; Min Yan; Zheng Gang Zhu; Sung Hoon Noh
Journal:  J Gastrointest Surg       Date:  2009-01-31       Impact factor: 3.452

6.  Comparison of colorectal and gastric cancer: survival and prognostic factors.

Authors:  Bijan Moghimi-Dehkordi; Azadeh Safaee; Mohammad R Zali
Journal:  Saudi J Gastroenterol       Date:  2009-01       Impact factor: 2.485

7.  Clinicopathological features of patients with middle third gastric carcinoma.

Authors:  Jin Hong Kim; Jae Kyoon Joo; Seong Yeob Ryu; Ho Gun Kim; Jae Hyuk Lee; Dong Yi Kim
Journal:  World J Gastrointest Oncol       Date:  2016-04-15

8.  Application of Weibull model for survival of patients with gastric cancer.

Authors:  Hui P Zhu; Xin Xia; Chuan H Yu; Ahmed Adnan; Shun F Liu; Yu K Du
Journal:  BMC Gastroenterol       Date:  2011-01-07       Impact factor: 3.067

9.  Adjuvant chemotherapy after gastric resection in node-positive cancer patients: a multicentre randomised study.

Authors:  B Neri; V de Leonardis; S Romano; F Andreoli; L M Pernice; L Bruno; D Borrelli; A Valeri; S Fabbroni; C Intini; G Cini
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

10.  Clinicopathological risk factors for gastric cancer: a retrospective cohort study in China.

Authors:  Kongwang Hu; Shuaili Wang; Zikun Wang; Longlong Li; Zhiguo Huang; Weiqiang Yu; Zhongxue Chen; Qing-Fa Wu
Journal:  BMJ Open       Date:  2019-09-20       Impact factor: 2.692

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.